Neutral Correlates of Risk-taking in Adolescents Exposed to Drugs

Status Completed

Clinical Trial Summary

Objective- To use fMRI to compare brain activity at rest and during memory and decision making tasks in normal children and in children exposed in utero to drugs of abuse.

Study population- All participants will be 14-20 year-olds enrolled in an ongoing longitudinal follow up study of children exposed to drugs of abuse in utero funded by NIH. A subgroup of this study cohort will be invited to participate based on added criteria needed for scanning studies, such as absence of metal in the body, no significant CNS disease, and ability to tolerate the scanning environment.

Design- Participants will undergo fMRI scans while performing a memory task, a decision making task and at rest. Data from participants in the current study may be combined with those from a previous study (NIDA protocol 417) which now reside in our repository protocol, 8002 and NIDA protocol 455.

Outcome measures- The primary outcome measures will be the difference in BOLD fMRI activation between drug-exposed participants and those without prenatal exposure to drugs of abuse.

Clinical Trial Description

Study Design

Related Conditions & MeSH terms

Exposure

Clinical Trial Details

NCT number	NCT01365988
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact
Status	Completed
Phase
Start date	May 15, 2011
Completion date	February 26, 2013

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04109677` - AIM CONTROL and SWECON - Handball The SWEdish CONcussion Study in Elite Handball
Not yet recruiting	`NCT04919434` - Intervention to Reduce Exposure to Environmental COntaminant (IRECO)	N/A
Completed	`NCT04064255` - Evaluation of Practical Body Image Therapy for Anorexia Nervosa V1	N/A
Completed	`NCT01450969` - New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)	N/A
Completed	`NCT05128981` - Internet-delivered Cognitive Behavioral Therapy Following Myocardial Infarction	N/A
Completed	`NCT01705938` - Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects	Phase 1
Completed	`NCT03712748` - Online Imaginal Exposure	N/A
Recruiting	`NCT04297462` - Different Regimens in Influenza Postexposure Chemoprophylaxis in Children	N/A
Completed	`NCT05322655` - PAthogen Transmission and Health Outcome Models of Enteric Disease
Completed	`NCT05158010` - Advancing Tools for Human Early Lifecourse Exposome Research and Translation- Adolescence Follow-up of the HELIX Subcohort	N/A
Recruiting	`NCT06208202` - Perceptions of E-Cigarettes and Synthetic Cooling Agents, The ICE Study	N/A
Recruiting	`NCT05079984` - Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain	N/A
Completed	`NCT03934697` - Imaginal Exposure II Study: In-Vivo	N/A
Completed	`NCT01087307` - Sample Collection Registry for Quality Control of Biological and Environmental Specimens and Assay Development and Testing
Recruiting	`NCT05869747` - Firefighter Collaborative Research Project	N/A
Completed	`NCT03414801` - Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects	N/A
Completed	`NCT02199535` - The Analysis of the Risks of the Personnel Working in Anesthesiology Departments in Turkey	N/A
Not yet recruiting	`NCT06338800` - One Session Virtual Reality During Ongoing Treatment for Anxiety: Feasibility in Children and Adolescents	N/A
Not yet recruiting	`NCT06323538` - Cohort Study on Plant-based Diets (COPLANT Study)

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Neutral Correlates of Risk-taking in Adolescents Exposed to Drugs Prenatally

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms